Albiglutide-induced pancreatitis. - Wikidata - awgldk - TriplyDB

Albiglutide-induced pancreatitis.

Albiglutide-induced pancreatitis.

http://www.wikidata.org/entity/Q42365383

about

Albiglutide-induced pancreatitis.

http://www.wikidata.org/entity/Q42365383

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Albiglutide-induced pancreatitis.

@en

Albiglutide-induced pancreatitis.

@nl

type

label

Albiglutide-induced pancreatitis.

@en

Albiglutide-induced pancreatitis.

@nl

prefLabel

Albiglutide-induced pancreatitis.

@en

Albiglutide-induced pancreatitis.

@nl

P1433

Q42365383-DCD1E33C-A5F1-470E-9379-00A47C5ED389

P1476

Q42365383-197AFFC9-DD1A-4954-A97C-3B4512673ADA

P2093

Q42365383-106A2C2E-98CB-49F8-A8CA-EA5FB643C01E

Q42365383-EB0FBDBB-A35A-4AF2-B25D-3DA735043200

P2860

Q42365383-0B417BE4-FA7C-474F-9D10-EAA7D2AE5714

Q42365383-14784084-56A5-41EF-BE25-3FC4104D3FB3

Q42365383-328D4CC3-EFA1-4661-9F1A-50D12E850FB9

Q42365383-3A7A58FA-2DAF-4FC9-8BCA-EFB6F38F9386

Q42365383-411E65F8-DE4B-4D03-9A34-A1D005E7D117

Q42365383-4973DEE7-45C0-409D-A27A-FC6D57E9D9DD

Q42365383-5AF68FD7-C6F4-47EE-8772-681EBE6BB226

Q42365383-5D44C7C5-A5F1-42EA-8CF0-94E73E60E776

Q42365383-5F981F55-AFEB-45F6-87E8-C10663A74FE7

Q42365383-7CB838E2-C5A9-4D32-902C-5C6590D4634C

P304

Q42365383-0CE115E4-964E-4E55-B0A3-FB0BD4800AC3

P31

Q42365383-369da0e6-d18c-403b-a4a8-b94d29c89a0d

Q42365383-719CB429-9667-46DD-AE06-512C1115CF9F

P356

Q42365383-EFF6DE2A-836E-41FE-9DB5-9C90ACEDB16E

P433

Q42365383-1DA5B020-50F7-43A4-AF62-9E6A302AC06F

P478

Q42365383-61914F5B-B005-401E-94B8-0614F4EE49F2

P50

Q42365383-17484209-64AC-4954-A145-D809CE1171C0

Q42365383-8CEDD523-F49E-40B3-8DCA-05CCC18A6FDC

P577

Q42365383-0979CE34-2ABF-46F4-8DF9-A8601ECF136E

P698

Q42365383-3D417CF6-690C-43FF-98FA-3EA2D087D16D

P932

Q42365383-EFFEDA92-A5AC-4581-9087-F9BBBD432EB5

P356

2042098616667352

P1433

Therapeutic advances in drug safety

P1476

Albiglutide-induced pancreatitis.

@en

P2093

Christopher W Sands

http://www.w3.org/2001/XMLSchema#string

Nidhi Jain

http://www.w3.org/2001/XMLSchema#string

P2860

A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond

Adverse Effects of GLP-1 Receptor Agonists

Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: data from the Italian AIFA Anti-diabetics Monitoring Registry.

Drug induced acute pancreatitis: does it exist?

Association of pancreatitis with glucagon-like peptide-1 agonist use.

Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes.

Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists.

Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.

Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes.

Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies.

P304

236-238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2042098616667352

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27904741

http://www.w3.org/2001/XMLSchema#string

P932

5117154

http://www.w3.org/2001/XMLSchema#string